E-intervention on Subclinical Fear of Cancer Recurrence
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Hong Kong
About this trial
The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.
Eligibility criteria
Qualifiers
Cantonese- or Mandarin-speaking Chinese cancer survivors
recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
had recently completed surgery as primary treatment
have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months
Disqualifiers
non-Chinese ethnicity
metastatic cancer
with current diagnosis of depression or psychosis or are currently receiving psychological treatments
language or intellectual difficulties that prevent them from understanding the intervention content
Trial design
Treatments tested in this trial
- eConquerFear-HK
- Basic Cancer Care
Treatment groups
48 Participants
are divided into 2 treatment groupsSponsors and collaborators
The University of Hong Kong
Lead sponsor
Health and Medical Research Fund
Collaborator
Source ClinicalTrials.gov